CBFB and acute myeloid leukemia: Since CBFB, SIN3A, and EP300 were all highly expressed in AML patients with higher SMANTIS expression values (Fig. 5a, Supplementary Data 4), we wondered whether SMANTIS is important for the recruitment of activatory or inhibitory co-factors of RUNX1.